Managing Withdrawal from Stimulants
If you aren’t yet aware of it, ASAM has provided a handy set of guidelines for physicians and other professionals in managing stimulant withdrawal syndromes in practice.
Select Page
by C. Scott McMillin | Jun 5, 2025 | Addiction Clinicians | 0 |
If you aren’t yet aware of it, ASAM has provided a handy set of guidelines for physicians and other professionals in managing stimulant withdrawal syndromes in practice.
by C. Scott McMillin | May 29, 2025 | Addictive Substances | 0 |
by C. Scott McMillin | Apr 17, 2025 | Resources | 0 |
by C. Scott McMillin | Apr 10, 2025 | Addiction | 0 |
by C. Scott McMillin | Feb 27, 2025 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 2, 2025 | In the News | 0 |
by C. Scott McMillin | Nov 11, 2024 | Addictive Substances | 0 |
…pink cocaine could be classified as a stimulant (MDMA), a psychedelic (the aforementioned 2-CB), and a dissociative anesthetic (ketamine). Along with whatever else the outlaw chemist may have had lying around the lab at the time.
Read Moreby C. Scott McMillin | Jul 22, 2024 | Treatment | 0 |
I’m curious as to whether the reductions in meth use could be expected to lead to eventual abstinence where meth was concerned. That’s been the hope for other maintenance treatments, for the most part unrealized.
Read Moreby C. Scott McMillin | Jul 8, 2024 | Treatment | 0 |
…we still haven’t made much progress in terms of agreeing on what qualifies as legitimate psychotherapy. Or perhaps more importantly, what doesn’t.
Read Moreby C. Scott McMillin | May 27, 2024 | Addiction | 0 |
Professional treatment is by definition time-limited; recovery is not. That journey doesn’t end. Peer-based support is often better able to meet future needs.
Read Moreby C. Scott McMillin | Apr 15, 2024 | Addictive Substances | 0 |
When I’ve seen people attempt to explain their motives, they usually blame it on the trust they had in their source — whoever gave or sold it to them at the time. That trust was misplaced, they complain.
Read Moreby C. Scott McMillin | Feb 15, 2024 | Addiction | 0 |
“I guess that proves that no meth is still better for you than using less meth.”
Read Moreby C. Scott McMillin | Dec 11, 2023 | Addictive Substances | 0 |
P2P has two advantages over traditional ephedrine-based meth, from the perspective of a cartel. First, as a true synthetic, there’s no natural upper limit on how much can be produced. Second, the P2P form is extremely cheap, both to make and sell.
Read Moreby C. Scott McMillin | Oct 16, 2023 | Addiction | 0 |
Extra naloxone doses were required to lift the victim out of a coma and lower the risk of respiratory arrest and death. Translation: New barriers to saving lives in the street. And more fatalities.
Read Moreby C. Scott McMillin | Jul 3, 2023 | In the News | 0 |
Today, the making and distributing of Captagon pills accounts for 90% or more of the foreign currency in Syrian government coffers, and $57 billion in annual revenue– far beyond the scope of Mexican cartels.
Read Moreby C. Scott McMillin | Jun 26, 2023 | Thinking About Addiction | 0 |
This in spite of the fact … that these drugs can and often do interact harmfully with one another. And regular users are at elevated risk for misuse, abuse, dependence, and/or addiction.
Read Moreby C. Scott McMillin | Mar 20, 2023 | Thinking About Addiction | 0 |
Which brings us to the issue of Supervised Injection Sites (SIS). An outbreak such as the one in New York is the strongest argument for these centers.
Read Moreby C. Scott McMillin | May 30, 2022 | Addictive Substances | 0 |
…one past error has been to overemphasize the more glamorous supply side interventions – interdiction and law enforcement – while paying much less attention to the demand side of the bargain.
Read More